Autoimmune Complications in Chronic Lymphocytic Leukaemia (CLL)

Clive S. Zent, Neil E. Kay

Research output: Contribution to journalReview articlepeer-review

66 Scopus citations


Patients with B-chronic lymphocytic leukaemia /small lymphocytic lymphoma (CLL) have a 5-10% risk of developing autoimmune complications, which primarily cause cytopaenia. These autoimmune cytopaenias can occur at any stage of CLL and do not have independent prognostic significance. The most common autoimmune complication is autoimmune haemolytic anaemia with a lower frequency of immune thrombocytopaenia and pure red blood cell aplasia and only rarely, autoimmune granulocytopaenia (AIG). Autoimmune cytopaenia should always be considered in the differential diagnosis of cytopaenia in patients with CLL. Patients with CLL can also have more than one form of autoimmune cytopaenia, which can occur together with bone-marrow failure. Treatment is usually effective but rarely curative for autoimmune cytopaenia complicating CLL. Optimal therapy will depend on a timely and accurate diagnosis of autoimmune cytopaenia and should be individualised according to the severity of the cytopaenia and the presence or absence of concomitant progressive CLL requiring therapy.

Original languageEnglish (US)
Pages (from-to)47-59
Number of pages13
JournalBest Practice and Research: Clinical Haematology
Issue number1
StatePublished - Mar 2010


  • autoimmune haemolytic anaemia
  • chronic lymphocytic leukaemia
  • immune thrombocytopaenia
  • pure red blood cell aplasia
  • small lymphocytic lymphoma

ASJC Scopus subject areas

  • Oncology
  • Clinical Biochemistry


Dive into the research topics of 'Autoimmune Complications in Chronic Lymphocytic Leukaemia (CLL)'. Together they form a unique fingerprint.

Cite this